title: XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML.
authors.affiliation: Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors.forename: Bing Z
authors.initials: BZ
authors.lastname: Carter
authors.forename: Duncan H
authors.initials: DH
authors.lastname: Mak
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Morris
authors.forename: Gautam
authors.initials: G
authors.lastname: Borthakur
authors.forename: Elihu
authors.initials: E
authors.lastname: Estey
authors.forename: Anna L
authors.initials: AL
authors.lastname: Byrd
authors.forename: Marina
authors.initials: M
authors.lastname: Konopleva
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
authors.forename: Michael
authors.initials: M
authors.lastname: Andreeff